Primary adenosine monophosphate (AMP) deaminase deficiency in a hypotonic infant

Manuel Castro-Gago1, Carmen Gómez-Lado, Laura Pérez-Gay

  • 1Servicio de Neuropediatría, Hospital Clínico Universitario, Facultad de Medicina, Universidad de Santiago de Compostela, Santiago de Compostela, Spain. manuel.castro.gago@usc.es

Journal of Child Neurology
|February 24, 2011
PubMed

Insights

Adenosine monophosphate (AMP) deaminase deficiency spectrum includes exercise-induced muscle pain and rare congenital weakness. This study identifies a homozygous mutation linked to congenital hypotonia, suggesting a primary AMP deaminase deficiency presentation.

Area of Science:

  • Biochemistry
  • Genetics
  • Neuromuscular Disorders

Background:

  • Adenosine monophosphate (AMP) deaminase deficiency presents a wide clinical spectrum, from asymptomatic carriers to exercise-induced myopathy.
  • Congenital muscle weakness and hypotonia have been rarely associated with AMP deaminase deficiency prior to molecular diagnostics.

Observation:

  • A 6-month-old female infant presented with congenital muscle weakness and hypotonia.
  • Genetic analysis revealed a homozygous C to T mutation at nucleotide 34 of the adenosine monophosphate deaminase-1 gene.

Findings:

  • The patient exhibited muscle deficiency of adenosine monophosphate deaminase.
  • This homozygous mutation is associated with congenital muscle weakness and hypotonia.

Implications:

  • This case suggests that primary adenosine monophosphate deaminase deficiency can manifest as congenital muscle weakness and hypotonia.
  • Highlights the importance of genetic analysis in diagnosing rare neuromuscular disorders.
  • Expands the known clinical spectrum of AMP deaminase deficiency.

Related Concept Videos

Hydrolysis of ATP01:08

Hydrolysis of ATP

The bonds of adenosine triphosphate (ATP) can be broken through the addition of water, releasing one or two phosphate groups in an exergonic process called hydrolysis. This reaction liberates the energy in the bonds for use in the cell—for instance, to synthesize proteins from amino acids.
If one phosphate group is removed, a molecule of ADP—adenosine diphosphate—remains, along with inorganic phosphate. ADP can be further hydrolyzed to AMP—adenosine monophosphate—by the removal of a second...
ATP Synthase: Structure01:18

ATP Synthase: Structure

ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...